Suchergebnisse - (Subject:"PARP inhibitor")

PubPharm (1.198)

71

Treatment of HRD-positive ovarian carcinosarcoma : A case report and literature review

enthalten in: Asian journal of surgery | 2023

von Lin, X. | Xu, H. | Liang, C. | +1

72

Cerebellar metastasis of ovarian cancer : a case report

enthalten in: Journal of medical case reports | 2023

von Cabitza, E. | Pirola, M. | Baldessari, C. | +12

73

Cerebellar metastasis of ovarian cancer: a case report

enthalten in: Journal of medical case reports | 2023

von Cabitza, E. | Pirola, M. | Baldessari, C. | +12

74

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38) : a phase IIIb trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2023

von Pujade-Lauraine, E. | Selle, F. | Scambia, G. | +21

CommentOn: Ann Oncol. 2023 Dec;34(12):1074-1076. - PMID 38072509

75

A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)

enthalten in: Journal of neuro-oncology | 2023

von Kleinberg, L. | Ye, X. | Supko, J. | +7

UpdateOf: Res Sq. 2023 Oct 24;:. - PMID 37961385

76

Effects of food and ethnicity on the pharmacokinetics of venadaparib, a next-generation PARP inhibitor, in healthy Korean, Caucasian, and Chinese male subjects

enthalten in: Investigational new drugs | 2023

von Kim, H. | Yang, E. | Lee, S. | +7

77

Safety, Tolerability, and Pharmacokinetics of Senaparib, a Novel PARP1/2 Inhibitor, in Chinese Patients With Advanced Solid Tumors : A Phase I Trial

enthalten in: The oncologist | 2023

von Cao, J. | Guo, H. | Ji, D. | +8

78

PSPC1 Inhibition Synergizes with Poly(ADP-ribose) Polymerase Inhibitors in a Preclinical Model of BRCA-Mutated Breast/Ovarian Cancer

enthalten in: International journal of molecular sciences | 2023

von Ghosh, M. | Kang, M. | Katuwal, N. | +5

79

Efficacy and safety of PARP inhibitors for maintenance treatment of ovarian cancer, regardless of BRCA or HRD status : a comprehensive updated meta-analysis

enthalten in: Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology | 2023

von Li, Y.

80

A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)

enthalten in: Journal of neuro-oncology | 2023

von Kleinberg, L. | Ye, X. | Supko, J. | +7